
Etyka Ośrodek Badań Klinicznych Tomasz Pesta S.K.A.
Other research and experimental development on natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2022-02-18
Limited partner contribution
50,000.00 PLN
Registered address
ul. 1 Maja 13/C, 10-117 Olsztyn, Poland
Website
Electronic delivery address
AE:PL-44458-41470-HVGFE-24
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed.
- 2025not filed
- 202429/06/2025
- 202310/07/2024
- 202230/05/2023
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Industry · Other research and experimental development on natural sciences and engineering341 / 1,557
Top 22%
Voivodeship · Warmińsko-Mazurskie3,130 / 9,285
Top 34%
Country · Poland169,589 / 496,512
Top 34%
Results vs industry
Revenue
This companyUSD 514.41kMedianUSD 73.13kAverageUSD 3.24m
Net profit
This companyUSD 180.57kMedianUSD 68.58AverageUSD 83.05k
Operating costs
This companyUSD 311.08kMedianUSD 75.83kAverageUSD 3.05m
Assets
This companyUSD 191.50kMedianUSD 120.25kAverageUSD 3.90m
Industry
Offer
- Conduct of clinical trials
- Phase II clinical trials
- Phase III clinical trials
- Phase IV clinical trials
Website technology
- Website
- WordPress
General partners
Manner of representation
The right to represent the company independently belongs to each general partner.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2022-03-01.
97 1240 5598 1978 0011 1181 6702
96 1240 5598 1111 0011 1181 6614
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Associated Medical Clinical Science Services sp. z o.o. | $1,449,035.10 | associated-medical.com.pl | ||
| Bioresearch Group sp. z o.o. | $776,186.19 | bioresearch.pl | ||
| Silmedic sp. z o.o. | $712,776.67 | silmedic.com.pl | ||
| MDR Regulator sp. z o.o. | $377,079.69 | pureclinical.eu | ||
| Clinical Research Group sp. z o.o. | $327,305.22 | crg-clinical.pl | ||
| Globe Badania Kliniczne sp. z o.o. | $283,646.38 | globebadania.pl | ||
| ETG Zamość sp. z o.o. | $260,151.02 | etg-network.com | ||
| Oncotarget Wojciech Jurczak S.K.A. | $192,291.27 | oncotarget.pl | ||
| IP Clinic sp. z o.o. | $135,932.95 | ipclinic.pl | ||
| CBK Med Clinic sp. z o.o. | $91,889.00 | cbkmedclinic.pl |
FAQ
The main business activity of Etyka Ośrodek Badań Klinicznych Tomasz Pesta focuses on other research and experimental development on natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on February 18, 2022.
The headquarters is located at: ul. 1 Maja 13, 10-117 Olsztyn.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of USD 514,415 in 2024, which is a decrease of 24.9% compared to 2023.
Yes, the company recorded a net profit of USD 180,567 in 2024, meaning the company decreased its profit by 46.4%.
The largest operating cost category falls under employee remuneration. This category amounted to USD 160,480 in 2024, representing 52% of all operating expenses.
Last updated: 2026-10-14